IFN-β Is a Highly Potent Inhibitor of Gastroenteropancreatic Neuroendocrine Tumor Cell GrowthIn Vitro

Cancer Research - United States
doi 10.1158/0008-5472.can-05-3043
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

The Tumor-Selective Cytotoxic Agent &Szlig;-Lapachone Is a Potent Inhibitor of IDO1

International Journal of Tryptophan Research
BiochemistryMolecular Biology
2013English

Targeting IFN- To B Cell Lymphoma by a Tumor-Specific Antibody Elicits Potent Antitumor Activities

Journal of Immunology
AllergyImmunology
2007English

The Cell Motility Modulator Slit2 Is a Potent Inhibitor of Platelet Function

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Neuroendocrine Neoplasms: A Brief Overview Emphasizing Gastroenteropancreatic Tumors

Autopsy and Case Reports
2017English

LncNEN885 Inhibits EMT Partially via WNT/Β-Catenin Signaling in Gastroenteropancreatic Neuroendocrine Neoplasms

Cancer Science
Cancer ResearchMedicineOncology
2018English

Small-Molecule P21-Activated Kinase Inhibitor PF-3758309 Is a Potent Inhibitor of Oncogenic Signaling and Tumor Growth

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

MicroRNA Analysis of Gastroenteropancreatic Neuroendocrine Tumors and Metastases

Oncotarget
Oncology
2018English

Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate

Cancer Prevention Research
MedicineCancer ResearchOncology
2011English

Resistance to Targeted Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy